BOSTON, MA--(Marketwire - April 17, 2012) - Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announced today that it will host the 'IN3 Medical Device 360° Boston' investor conference on June 27-29, 2012, at the Hyatt Regency Boston.
Investment in Innovation (IN3) Medical Device 360° Boston, being held in the hub of medtech investment and innovation on the East Coast, will feature presentations by more than 25 early-, mid- and late-stage start-up companies that are seeking funding and/or strategic partnership, developing products covering the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panels, networking sessions and meet-and-greets with industry thought leaders discussing the most pressing issues facing the global device industry in 2012 and beyond.
Participating speakers confirmed to date include senior-level investors from Ascent Biomedical Ventures, Cowen Healthcare Royalty Partners, Fidelity Biosciences, NGN Capital, NMT Capital, Novartis Venture Fund, Siemens Venture Capital, and many more. Interactive panel topics will include: Strategic View Point -- What Big Companies Want to See in a Start-Up Before Buying; Complying with the New Physician Sunshine Law Governing Industry's Disclosure of Physician Relationships; and Medtech Investing -- Hear What It Takes to Get a VC to Say Yes! In addition, Robert Pearson, president of W20 Group, will give a special Social Media Keynote Presentation, and a networking cocktail reception will be held the evening of June 28th. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.
This two-day special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in Boston should contact Kayleen Kell at 949-797-7142, or email firstname.lastname@example.org.
The event will be held at the Hyatt Regency Boston, centrally located in downtown Boston. Co-sponsors to date include Ronald Trahan Associates Inc., AptivSolutions, Medmarc with The Hartford and Biomedic-Insure, UBM TechInsights, FreeMind, Scisive, Mass Medical Angels, Life Science Intelligence, and Marketwire. Visit www.IN3Boston.com for full conference and registration details. EBI will be hosting one additional IN3 Medical Device 360° event in 2012, its Summit-San Francisco, October 15-17; visit http://www.elsevierbi.com/conferences for more information.
About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.